Гифомицеты - продуценты циклодепсипептидных соединений
Аннотация
Об авторах
М. В. БибиковаРоссия
Т. О. Пужевская
Россия
А. В. Катлинский
Россия
Список литературы
1. Ballard C. E., Yu H. Wang B. Recent development in depsipeptide research. Curr Med Chem 2002; 9: 471-498.
2. Шемякин М. М., Хохлов А. С., Антонов В. К. Антибиотики-депсипептиды. Химия антибиотиковю М.: 2: 1161-1172.
3. Шредер Э, Любке К. Пептиды, из-во «Мир». 1969.
4. Jestoi M., Rokka M., Rizzo A. et al. Determination of Fusarium-mycotoxins beauvericin and enniatins with liquid chromatography - tandem mass spec-trometry(LC-MS/MS). J Liq Chromatogr Technol 2005; 28: 369-381.
5. Potterat O., Wagner K., Haag H. Liquid chromatography-electrospray time-of-flight mass spectrometry for on-line accurate mass determination and identification of cyclodepsipeptides in a crude extract of the fungus Metarrhizium anisopliae. J Chromatography 2000; 872: 85-90.
6. Fotie J., Morgan R. E. Depsipeptides from microorganisms: a new class of antimalarials. Mini Rev Med Chem 2008; 11: 1088-1094.
7. Sarabia F., Chammaa S., Ruiz A. S. et al. Chemistry and biology of cyclic depsipeptides of medicinal and biological interest. Current Medicinal Chemistry, 2004; 11: 1309-1332.
8. Овчинников Ю. А., Иванов В. Т., Шкроб A. M. Мембраноактивные комплексоны, М.: 1974.
9. Dongwoo Shin, Yosup Rew, Dale L. Boger. Total synthesis and structure of the ramoplanin A1 and A3 aglycones: two minor components of the ramoplanin complex. Proceed Nat Acad Sci 2004; 101: 11977-11979.
10. Fulco P., Wenzel R. P. Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent. Expert Rev Anti Infect Ther 2006; 4: 939-945.
11. Heike Brötz-Oesterhelt, Dieter Beyer, Hein-Peter Kroll et al. Disregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med 2005; 11: 1082-1087.
12. Breukink E., de Kruijff B. Lipid II as a target for antibiotics. Nat Rev. Drug Discov 2006; 5: 321-330.
13. Xiao Fang, Kittichoat Tiyanont, Yi Zhang, et al. The mechanism of action of ramoplanin and enduracidin. Mol BioSyst 2006; 2: 69-76.
14. Pohanka A. Antifungal antibiotics from potential biocontrol microorganisms// Doctoral diss. Dept Chem SLU. Acta Univers Agricul Sueciae 2006; 47.
15. Schulz B., Boyle C., Siegfried D. S. et al. Endophytic fungi: a source of novel biologically active secondary metabolites. Mycol Res 2002; 106: 996-1004.
16. Pedras M. S., Irina Zaharia L., Ward D. E. The destruxins: synthesis, biosynthesis, biotransformation, and biological activity. Phytochemistry. 2002; 59: 579-596.
17. Gupta S., Roberts D. W., Renwick J. A. Insecticidal cyclodepsipeptides from Metarrhizium anisopliae. J Chem Soc Perkin Trans I. 1989; 2347-2357.
18. Che Y., Swenson D. C., Gloer J. B. et al. Pseudodestruxins A and B: new cyclic depsipeptides from the coprophilous fungus Nigrosabulum globo-sum. J Nat Prod 2001; 64: 555-558.
19. Lira S. P., Vita-Marques A. M., Seleghim M. H. et al. New destruxins from the marine-derived fungus Beauveria felina. J Antibiot 2006; 59: 553-563.
20. Бибикова М. В., Пужевская Т. О., Даниленко А. H. и др. Образование деструксинов копротрофным штаммом Beauveria feline №7. Антибиотики и химиотер. В печати.
21. Baute R., Deffieux G., Merlet D. et al. New insecticidal cyclodepsipeptides from the fungus Isaria felina. I. Production, isolation and insecticidal properties of isariins B, C and D. J Antibiotics 1981; 34: 1261-1265.
22. Sabareesh V., Ranganayaki R. S., Raghothama S. et al. Identification and сharacterization ofa library of microheterogeneous cyclohexadep-sipeptides from the fungus Isaria. Amer Chem Soc 2007; 70: 5.
23. Boros C., Smith C. J., Vasina Y.et al. Isolation and identification of the icosalides - cyclic peptolides with selective antibiotic and cytotoxic activities. J.Antibiotics 2006; 59: 486-489.
24. Oh D. C., Kauffman C. A., Jensen P. R., Fenical W. Induced production of emericellamides A and B from the marine-derived fungus Emericella sp. in competing co-culture. J Nat Prod 2007; 70: 515-520.
25. Tabudravu J. N., Morris L. A., Milne B. F., Jaspars M. Conformational studies of free and Li+ complexed jasplakinolide, a cyclic depsipeptide from the Fijian marine sponge Jaspis splendens. Organic Biomol Chem 2005; 3: 745-749.
26. Kaida K., Fudou R., Kameyama T. et al. New cyclic depsipeptide antibiotics clavariopsins A and B, produced by an aquatic hyphomycete Claviriopsis aquatica. J. Antibiotics 2001; 54: 22-28.
27. Lee K. K. et al. Petriellin A, a fungicidal 13-depsipeptide. J Org Chem 1995; 60: 5384-5387.
28. Sato T., Ishiyama D., Honda R. et al. Glomosporin, a novel antifungal cyclic depsipeptide from Glomospora sp. 1. Production, isolation, physico-chemical and biological activities. J Antibiotics 2000; 53: 597-602.
29. Yano T., Aoyagi A., Kozuma S. et al. Pleofungins, novel inositol phosphoryl-ceramide synthase inhibitors, from Phoma sp. SANK 13899. I. Taxonomy, fermentation, isolation, and biological activities. Ibid 2007; 60: 43-51.
30. Aoyagi A., Yano T., Kozuma S., Takatsu T. Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. II. Structural elucidation. Ibid 2007; 60: 136-142.
31. Cerantola V., Guillas I., Roubaty C. et al. Aureobasidin A arrests growth of yeast cells through both ceramide intoxication and deprivation of essential inositolphosphorylceramides. Mol Microbiol 2009; 71: 1523-1537.
32. Yan K., Zhang Y., Huang R. et al. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment off. Natural products and antifungal drug discovery. Methods Mol Med 2007; 2.
33. Chen H. C., Chou C. K., Sun C. M., Yeh S. F. Suppressive effects of destruxin B on hepatitis B virus surface antigene gene expression in human hepatoma cells. Antiviral Res 1997; 34: 137-144.
34. Yeh S. F., Pan W., Ong G. T. Study of structure-activity correlation in destruxins, a class of cyclodepsipeptides possessing suppressive effect on the generation of hepatitis B virus surface antigen in human hepatoma cells. Biochem Biophys Res Commun 1996; 229: 65-72.
35. Hamel E., Covell D. G. Antimitotic Peptides and depsipeptide. Cur Med Chem - Anti-Cancer Agents 2002; 2: 19-53.
36. Mitsiades C. S., Ocio E. M., Pandiella A. et al. Aplidin, a marine organism - derived compound with potent antimyeloma activity in vitro and in vivo. Cancer Res 2008; 68: 5216-5225.
37. Calo L.Cytotoxic effects of the mycotoxin beauvericin on human cell lines of myeloid origin. Pharmacol Res 2004; 49: 73-77.
38. Pocsfalvi G., Di Landa G., Ferranti P. et al. Observation of non-covalent interactions between beauvericin and oligonucleotides using electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 1997; 11: 265-272.
39. Zhan J, Burns A. M., Liu M. X. et al. Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum. J Nat Prod 2007; 70: 227-232.
40. Klaric M. S., Pepeljinjak S. Beauvericin chemical and biological aspects and occurrence.Arh. Hig Rada Toxikol 2005; 5: 343-350.
41. Isaka M., Palasarn S., Lapanun S., Sriklung K. Paecilodepsipeptide A, an antimalarial and antitumor cyclohexadepsipeptide from the insect pathogenic fungus Paecilomyces cinnamomeus BCC 9616. J Nat Prod 2007; 70: 675-678.
42. Ueda H., Nakajima H., Hor Y., et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiotics 1994; 47: 301-310.
43. Shigematsu N., Ueda H., Takase S. et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination. Ibid 1994; 47: 311-314.
44. Dangond Fernando. (W0/2003/083067) Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic sclerosis and Alzheimers disease. (Netherlands).
45. Tomoda H., Huang X. H., Cao J. et al. Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics. J Antibiotics 1992; 45: 1626-1632.
46. Ohshiro T., Rudel L. L., Omura S., Tomoda H. Selectivity of microbial acyl-CoA - cholesterol acyltransferase inhibitors toward isozymes. J Antib 2007; 69: 43-51.
47. Ohshiro T., Rudel L. L., Omura S., Tomoda H. Compared with acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin: cholesterol acyltransferase (ACAT2) displays the greatest capacity to differentiate cholesterol from sitosterol. J Biol Chem 2003.
48. Namatame I. H. Tomoda, Satoshi Omura. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. J Antibiotics 1996; 49: 73-77.
49. Jegorov A., Sedmera P., Matha V. Beauverolides L and La from Beauveria tenella and Paecilomyces fumosoroseus. Phytochemystry 1994; 37: 1300-1303.
50. Matsuda D., Namatame I., Tomoda H. et al. New beauveriolides produced by amino acid-supplemented fermentation of Beauveria sp. FO-6979. J Antibiotics 2004; 57: 1-9.
51. Naganuma S., Kuzuya N., Sakai K. et al. Inhibition of the accumulation of lipid droplets in macrophage J774 by bafilomycin B1 and destruxin E. Biochim Biophys Acta 1992; 1126: 41-48.
52. Nagai К., Woo J.T. Destruxins, cyclodepsipeptides block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts. Bone 2003; 33: 443-455.
53. Muroi M., Shiragami N., Takatsuki A. Destruxin B, a specific and readily reversible inhibitor of vacular-type H+ translocation ATPase. Biochem Biophys. Res Com 1994; 205: 1555-1563.
54. Hih-Yung Tang, Yi-Wen Chen et al. Beauvericin activated Ca2+- activated CI- current and deaths in Xenopus oocytes via influx of extracellular Ca2+. Chem Res Toxicol 2002; 15: 854-860.
55. Tsunoo A., Kamijo M. Non-cyclic AMP-dependent, positive inotropic cyclodepsipeptides with negative chronotropy1. J Pharm Exper Ther 1999; 290: 1006-1012.
56. Akinobu Tsunoo, Masayuki Kamijo, Naoki Taketomo et al. Roseocardin, a novel cardiotonic cyclodepsipeptide from Trichothecium roseum TT103. J Antibiiotics 1997; 50: 1007-1013.
57. Cai Р., Smith D., Katz B. et al. Destruxin-A4 chlorohydrin, a novel destruxin from fugus OS-F68576: isolation, structure determination, and biological activity as an inducer of erythropoietin. J Nat Prod 1998; 61: 290-293.
58. Hamano K., Kinoshita M., Furuya K. et al. Leualacin, a novel calcium blocker from Hapsidospora irregularis I. Taxonomy, fermentation, isolation. physico-chemical and biological properties. J Antibiotics 1992; 45: 899.
59. Pal S., St Leger R. J., Wu L. P. Fungal peptide destruxin A plays a specific role in suppressing the innate immune response in Drosophila melanogaster. J Biol Chem 2007; 282: 8969-8977.
Рецензия
Для цитирования:
Бибикова М.В., Пужевская Т.О., Катлинский А.В. Гифомицеты - продуценты циклодепсипептидных соединений. Антибиотики и Химиотерапия. 2010;55(3-4):35-44.
For citation:
Bibikova M.V., Puzhevskaya T.O., Katlinsky A.V. Hyphomycetes, as Organisms Producing Cyclodepsipeptides. Antibiot Khimioter = Antibiotics and Chemotherapy. 2010;55(3-4):35-44. (In Russ.)